Caitlin R Sacha1,2, Jorge E Chavarro3, Paige L Williams3, Jennifer Ford3, LiHua Zhang4, Patricia K Donahoe4, Irene C Souter5, Russ Hauser3, David Pépin6, Lidia Mínguez-Alarcón3. 1. Pediatric Surgical Research Laboratories, Massachusetts General Hospital and Harvard Medical School, 185 Cambridge Street, Boston, MA, 02114, USA. csacha@partners.org. 2. MGH Fertility Center and Harvard Medical School, Boston, MA, USA. csacha@partners.org. 3. Harvard T.H. Chan School of Public Health, Boston, MA, USA. 4. Pediatric Surgical Research Laboratories, Massachusetts General Hospital and Harvard Medical School, 185 Cambridge Street, Boston, MA, 02114, USA. 5. MGH Fertility Center and Harvard Medical School, Boston, MA, USA. 6. Pediatric Surgical Research Laboratories, Massachusetts General Hospital and Harvard Medical School, 185 Cambridge Street, Boston, MA, 02114, USA. David.pepin@mgh.harvard.edu.
Abstract
PURPOSE: To enhance the understanding of the clinical significance of anti-Müllerian hormone (AMH) in follicular fluid, we aimed to determine the variability of AMH concentrations in follicular fluid within and across IVF cycles and whether high follicular fluid AMH concentrations are associated with improved clinical IVF outcomes. METHODS: This was a retrospective cohort study of companion follicular fluid and serum samples from 162 women enrolled in the Environment and Reproductive Health (EARTH) Study between 2010 and 2016. AMH concentrations were quantified using a sandwich enzyme-linked immunosorbent assay. Spearman correlation and intra-class correlation (ICC) were calculated to assess variability of follicular fluid AMH, and generalized linear mixed models were used to evaluate the associations of FF AMH with IVF outcomes. RESULTS: The median (interquartile range, IQR) age of the 162 women was 34.0 years (32.0, 37.0). Follicular fluid AMH concentrations were highly correlated between follicles within each IVF cycle (Spearman r = 0.78 to 0.86) and across cycles for each woman (ICC 0.87 (95% CI 0.81 to 0.92)). Compared with women in the highest tertile of FF AMH (mean AMH = 2.3 ng/ml), women in the lowest tertile (mean AMH = 0.2 ng/ml) had lower serum AMH (T1 = 0.1 ng/ml vs. T3 = 0.6 ng/ml, p < 0.0001). In adjusted models, higher tertiles of follicular fluid AMH concentrations were associated with lower mean endometrial thickness and higher probability of clinical pregnancy. CONCLUSIONS: Follicular fluid AMH concentrations show little variability between pre-ovulatory follicles, and higher pre-ovulatory follicular fluid AMH may predict a higher probability of clinical pregnancy.
PURPOSE: To enhance the understanding of the clinical significance of anti-Müllerian hormone (AMH) in follicular fluid, we aimed to determine the variability of AMH concentrations in follicular fluid within and across IVF cycles and whether high follicular fluid AMH concentrations are associated with improved clinical IVF outcomes. METHODS: This was a retrospective cohort study of companion follicular fluid and serum samples from 162 women enrolled in the Environment and Reproductive Health (EARTH) Study between 2010 and 2016. AMH concentrations were quantified using a sandwich enzyme-linked immunosorbent assay. Spearman correlation and intra-class correlation (ICC) were calculated to assess variability of follicular fluid AMH, and generalized linear mixed models were used to evaluate the associations of FF AMH with IVF outcomes. RESULTS: The median (interquartile range, IQR) age of the 162 women was 34.0 years (32.0, 37.0). Follicular fluid AMH concentrations were highly correlated between follicles within each IVF cycle (Spearman r = 0.78 to 0.86) and across cycles for each woman (ICC 0.87 (95% CI 0.81 to 0.92)). Compared with women in the highest tertile of FF AMH (mean AMH = 2.3 ng/ml), women in the lowest tertile (mean AMH = 0.2 ng/ml) had lower serum AMH (T1 = 0.1 ng/ml vs. T3 = 0.6 ng/ml, p < 0.0001). In adjusted models, higher tertiles of follicular fluid AMH concentrations were associated with lower mean endometrial thickness and higher probability of clinical pregnancy. CONCLUSIONS: Follicular fluid AMH concentrations show little variability between pre-ovulatory follicles, and higher pre-ovulatory follicular fluid AMH may predict a higher probability of clinical pregnancy.
Authors: Motohiro Kano; Amanda E Sosulski; LiHua Zhang; Hatice D Saatcioglu; Dan Wang; Nicholas Nagykery; Mary E Sabatini; Guangping Gao; Patricia K Donahoe; David Pépin Journal: Proc Natl Acad Sci U S A Date: 2017-01-30 Impact factor: 11.205
Authors: Laura Pellatt; Suman Rice; Nafi Dilaver; Amira Heshri; Raymond Galea; Mark Brincat; Kristy Brown; Evan R Simpson; Helen D Mason Journal: Fertil Steril Date: 2011-09-13 Impact factor: 7.329
Authors: David B Seifer; David T MacLaughlin; Benjamin P Christian; Bo Feng; Robert M Shelden Journal: Fertil Steril Date: 2002-03 Impact factor: 7.329
Authors: S Dyer; G M Chambers; J de Mouzon; K G Nygren; F Zegers-Hochschild; R Mansour; O Ishihara; M Banker; G D Adamson Journal: Hum Reprod Date: 2016-05-20 Impact factor: 6.918
Authors: Carmen Messerlian; Paige L Williams; Jennifer B Ford; Jorge E Chavarro; Lidia Mínguez-Alarcón; Ramace Dadd; Joseph M Braun; Audrey J Gaskins; John D Meeker; Tamarra James-Todd; Yu-Han Chiu; Feiby L Nassan; Irene Souter; John Petrozza; Myra Keller; Thomas L Toth; Antonia M Calafat; Russ Hauser Journal: Hum Reprod Open Date: 2018-02-20
Authors: Audrey J Gaskins; Kelvin C Fong; Yara Abu Awad; Qian Di; Lidia Mínguez-Alarcón; Jorge E Chavarro; Jennifer B Ford; Brent A Coull; Joel Schwartz; Itai Kloog; Irene Souter; Russ Hauser; Francine Laden Journal: Environ Health Perspect Date: 2019-07-03 Impact factor: 9.031
Authors: J V Jeppesen; R A Anderson; T W Kelsey; S L Christiansen; S G Kristensen; K Jayaprakasan; N Raine-Fenning; B K Campbell; C Yding Andersen Journal: Mol Hum Reprod Date: 2013-04-04 Impact factor: 4.025